MKP3 eliminates depolarization-dependent neurotransmitter release through downregulation of L-type calcium channel Cav1.2 expression

Cell Calcium

Volumn 53, Issue 3, 2013, Pages 224-230

  Mortensen, Ole V ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Exocytosis; Gene expression; Map kinase; Pc12 cells; Phosphatase; Signaling; Voltage gated calcium channel

Indexed keywords

CALCIMYCIN; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL L TYPE CAV1.2; DOPAMINE; DUAL SPECIFICITY PHOSPHATASE 6; IONOPHORE; LATROTROXIN; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DEPOLARIZATION; DOPAMINE RELEASE; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; IMMUNOBLOTTING; NONHUMAN; PC12 CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

RATTUS;

ANIMALS; CALCIUM CHANNELS, L-TYPE; DOWN-REGULATION; DUAL SPECIFICITY PHOSPHATASE 6; NEUROTRANSMITTER AGENTS; PC12 CELLS; RATS;

EID: 84875256952     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2012.12.004     Document Type: Article

References (46)

1. Wojcik S.M., Brose N. Regulation of membrane fusion in synaptic excitation-secretion coupling: speed and accuracy matter. Neuron 2007, 55:11-24.
2. Waites C.L., Garner C.C. Presynaptic function in health and disease. Trends in Neurosciences 2011, 34:326-337.
3. Sudhof T.C. The synaptic vesicle cycle. Annual Review of Neuroscience 2004, 27:509-547.
4. Ghijsen W.E., Leenders A.G. Differential signaling in presynaptic neurotransmitter release. Cellular and Molecular Life Sciences 2005, 62:937-954.
5. Leenders A.G., Sheng Z.H. Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity. Pharmacology and Therapeutics 2005, 105:69-84.
6. Catterall W.A., Few A.P. Calcium channel regulation and presynaptic plasticity. Neuron 2008, 59:882-901.
7. Lawrence M.C., Jivan A., Shao C., Duan L., Goad D., Zaganjor E., Osborne J., McGlynn K., Stippec S., Earnest S., Chen W., Cobb M.H. The roles of MAPKs in disease. Cell Research 2008, 18:436-442.
8. Jovanovic J.N., Czernik A.J., Fienberg A.A., Greengard P., Sihra T.S. Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nature Neuroscience 2000, 3:323-329.
9. Kushner S.A., Elgersma Y., Murphy G.G., Jaarsma D., van Woerden G.M., Hojjati M.R., Cui Y., LeBoutillier J.C., Marrone D.F., Choi E.S., De Zeeuw C.I., Petit T.L., Pozzo-Miller L., Silva A.J. Modulation of presynaptic plasticity and learning by the H-ras/extracellular signal-regulated kinase/synapsin I signaling pathway. Journal of Neuroscience 2005, 25:9721-9734.
10. Subramanian J., Morozov A. Erk1/2 inhibit synaptic vesicle exocytosis through L-type calcium channels. Journal of Neuroscience 2011, 31:4755-4764.
11. Dickinson R.J., Keyse S.M. Diverse physiological functions for dual-specificity MAP kinase phosphatases. Journal of Cell Science 2006, 119:4607-4615.
12. Kodama M., Russell D.S., Duman R.S. Electroconvulsive seizures increase the expression of MAP kinase phosphatases in limbic regions of rat brain. Neuropsychopharmacology 2005, 30:360-371.
13. Xiang G., Pan L., Xing W., Zhang L., Huang L., Yu J., Zhang R., Wu J., Cheng J., Zhou Y. Identification of activity-dependent gene expression profiles reveals specific subsets of genes induced by different routes of Ca(2+) entry in cultured rat cortical neurons. Journal of Cellular Physiology 2007, 212:126-136.
14. Helton T.D., Xu W., Lipscombe D. Neuronal L-type calcium channels open quickly and are inhibited slowly. Journal of Neuroscience 2005, 25:10247-10251.
15. Pan J.Q., Lipscombe D. Alternative splicing in the cytoplasmic II-III loop of the N-type Ca channel alpha 1B subunit: functional differences are beta subunit-specific. Journal of Neuroscience 2000, 20:4769-4775.
16. Ushkaryov Y.A., Rohou A., Sugita S. alpha-Latrotoxin and its receptors. Handbook of Experimental Pharmacology 2008, 184:171-206.
17. Mandela P., Ordway G.A. The norepinephrine transporter and its regulation. Journal of Neurochemistry 2006, 97:310-333.
18. Mortensen O.V., Amara S.G. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters. Journal of Neurochemistry 2006, 98:1531-1540.
19. Mandela P., Ordway G.A. KCl stimulation increases norepinephrine transporter function in PC12 cells. Journal of Neurochemistry 2006, 98:1521-1530.
20. Pereira D.B., Carvalho A.P., Duarte C.B. Non-specific effects of the MEK inhibitors PD098,059 and U0126 on glutamate release from hippocampal synaptosomes. Neuropharmacology 2002, 42:9-19.
21. Schonn J.S., Desnos C., Henry J.P., Darchen F. Transmitter uptake and release in PC12 cells overexpressing plasma membrane monoamine transporters. Journal of Neurochemistry 2003, 84:669-677.
22. 2+ channels in rat phaeochromocytoma cell lines. Journal of Physiology 1990, 426:95-116.
23. 2+ channels in PC12 cells. Journal of Neuroscience 1996, 16:7557-7565.
24. Janigro D., Maccaferri G., Meldolesi J. Calcium channels in undifferentiated PC12 rat pheochromocytoma cells. FEBS Letters 1989, 255:398-400.
25. 2+ channels coupled to exocytosis in pheochromocytoma (PC12) cells. Journal of Neurochemistry 1999, 73:874-880.
26. Vaudry D., Stork P.J., Lazarovici P., Eiden L.E. Signaling pathways for PC12 cell differentiation: making the right connections. Science 2002, 296:1648-1649.
27. Levine E.S., Dreyfus C.F., Black I.B., Plummer M.R. Differential effects of NGF and BDNF on voltage-gated calcium currents in embryonic basal forebrain neurons. Journal of Neuroscience 1995, 15:3084-3091.
28. 2+ channel synthesis in developing hippocampal neurons. European Journal of Neuroscience 2000, 12:4017-4032.
29. Fitzgerald E.M. Regulation of voltage-dependent calcium channels in rat sensory neurones involves a Ras-mitogen-activated protein kinase pathway. Journal of Physiology 2000, 527(Pt 3):433-444.
30. Woodall A.J., Richards M.A., Turner D.J., Fitzgerald E.M. Growth factors differentially regulate neuronal Cav channels via ERK-dependent signalling. Cell Calcium 2008, 43:562-575.
31. Pollock J.D., Rane S.G. p21ras signaling is necessary but not sufficient to mediate neurotrophin induction of calcium channels in PC12 cells. Journal of Biological Chemistry 1996, 271:8008-8014.
32. Bloch-Shilderman E., Jiang H., Abu-Raya S., Linial M., Lazarovici P. Involvement of extracellular signal-regulated kinase (ERK) in pardaxin-induced dopamine release from PC12 cells. Journal of Pharmacology and Experimental Therapeutics 2001, 296:704-711.
33. Marchetti S., Gimond C., Chambard J.C., Touboul T., Roux D., Pouyssegur J., Pages G. Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation. Molecular and Cellular Biology 2005, 25:854-864.
34. Boschert U., Dickinson R., Muda M., Camps M., Arkinstall S. Regulated expression of dual specificity protein phosphatases in rat brain. Neuroreport 1998, 9:4081-4086.
35. Takaki M., Ujike H., Kodama M., Takehisa Y., Nakata K., Kuroda S. Two kinds of mitogen-activated protein kinase phosphatases, MKP-1 and MKP-3, are differentially activated by acute and chronic methamphetamine treatment in the rat brain. Journal of Neurochemistry 2001, 79:679-688.
36. Mortensen O.V., Larsen M.B., Prasad B.M., Amara S.G. Genetic complementation screen identifies a mitogen-activated protein kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking. Molecular Biology of the Cell 2008, 19:2818-2829.
37. Bhat S., Dao D.T., Terrillion C.E., Arad M., Smith R.J., Soldatov N.M., Gould T.D. CACNA1C (Ca(v)1.2) in the pathophysiology of psychiatric disease. Progress in Neurobiology 2012, 99:1-14.
38. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., Napolitano C., Schwartz P.J., Joseph R.M., Condouris K., Tager-Flusberg H., Priori S.G., Sanguinetti M.C., Keating M.T. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119:19-31.
39. Lee K.Y., Ahn Y.M., Joo E.J., Chang J.S., Kim Y.S. The association of DUSP6 gene with schizophrenia and bipolar disorder: its possible role in the development of bipolar disorder. Molecular Psychiatry 2006, 11:425-426.
40. Kim S.H., Shin S.Y., Lee K.Y., Joo E.J., Song J.Y., Ahn Y.M., Lee Y.H., Kim Y.S. The genetic association of DUSP6 with bipolar disorder and its effect on ERK activity. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 37:41-49.
41. Higgs B.W., Elashoff M., Richman S., Barci B. An online database for brain disease research. BMC Genomics 2006, 7:70.
42. Struyf J., Dobrin S., Page D. Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia. BMC Genomics 2008, 9:531.
43. Dao D.T., Mahon P.B., Cai X., Kovacsics C.E., Blackwell R.A., Arad M., Shi J., Zandi P.P., O'Donnell P., Knowles J.A., Weissman M.M., Coryell W., Scheftner W.A., Lawson W.B., Levinson D.F., Thompson S.M., Potash J.B., Gould T.D. Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biological Psychiatry 2010, 68:801-810.
44. Bodi I., Mikala G., Koch S.E., Akhter S.A., Schwartz A. The L-type calcium channel in the heart: the beat goes on. Journal of Clinical Investigation 2005, 115:3306-3317.
45. Maillet M., Purcell N.H., Sargent M.A., York A.J., Bueno O.F., Molkentin J.D. DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility. Journal of Biological Chemistry 2008, 283:31246-31255.
46. Molina G., Vogt A., Bakan A., Dai W., Queiroz de Oliveira P., Znosko W., Smithgall T.E., Bahar I., Lazo J.S., Day B.W., Tsang M. Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages. Nature Chemical Biology 2009, 5:680-687.